Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-20

FDA Approved: BIMATOPROST — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved a supplemental application for bimatoprost from Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)